Table 1 Clinical characteristics of neurotrophins and receptors in the synovial fluids of SpA, RA, and OA patients
From: Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis
Patient Groups | Â | Clinical characteristics | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|  |  | age | gender | DD (y) | SJC | TJC | CRP (mg/l) | ESR (mm) | SFc/μl | %PMN |
SpA (n = 16) | median | 37 | 6 f/10 m | 5 | 2* | 1* | 10.5* | 20 | 7025* | 72 |
| Â | SD | 16.8 | Â | 5.9 | 1.2 | 1.9 | 23 | 15 | 8825 | 26 |
| Â | (range) | (16 to 65) | Â | (0.3 to 18) | (1 to 4) | (0 to 8) | (1 to 99) | (3 to 54) | (2500 to 31100) | (5 to 92) |
RA (n = 9) | median | 49 | 8 f/1 m | 5 | 5# | 3# | 11.7# | 26 | 7950# | 76 |
| Â | SD | 15.3 | Â | 9.2 | 3.2 | 1.8 | 29 | 8.8 | 3645 | 11 |
| Â | (range) | (37 to 77) | Â | (1 to 26) | (2 to 13) | (2 to 7) | (7.5 to -95) | (12 to 67) | (2600 to 1300) | (50 to 90) |
OA (n = 7) | median | 67 | 5 f/2 m | 6 | 1 | 1 | 3 | 17 | 700 | 60 |
| Â | SD | 5.8 | Â | 5.7 | 0.5 | 0.4 | 1.1 | 5.6 | 1096 | 33 |
| Â | (range) | (58 to 75) | Â | (2 to 18) | (1 to 2) | (1 to 2) | (1.6 to 4.5) | (12 to 25) | (100 to 3250) | (5 to 90) |